KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) Non Operating Income: 2009-2025

Historic Non Operating Income for Lam Research (LRCX) over the last 17 years, with Q3 2025 value amounting to $30.1 million.

  • Lam Research's Non Operating Income fell 2.33% to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year decrease of 8626.63%. This contributed to the annual value of $57.2 million for FY2025, which is 4064.83% down from last year.
  • Lam Research's Non Operating Income amounted to $30.1 million in Q3 2025, which was down 2.33% from $37.9 million recorded in Q2 2025.
  • Lam Research's 5-year Non Operating Income high stood at $37.9 million for Q2 2025, and its period low was -$120.4 million during Q2 2022.
  • In the last 5 years, Lam Research's Non Operating Income had a median value of $2.6 million in 2023 and averaged -$6.0 million.
  • As far as peak fluctuations go, Lam Research's Non Operating Income plummeted by 158082.61% in 2022, and later skyrocketed by 118294.81% in 2024.
  • Lam Research's Non Operating Income (Quarter) stood at $18.0 million in 2021, then plummeted by 256.86% to -$28.2 million in 2022, then surged by 205.68% to $29.8 million in 2023, then plummeted by 52.2% to $14.3 million in 2024, then skyrocketed by 110.87% to $30.1 million in 2025.
  • Its Non Operating Income stands at $30.1 million for Q3 2025, versus $37.9 million for Q2 2025 and -$25.0 million for Q1 2025.